{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T23:10:46Z","timestamp":1768259446626,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s11060-024-04764-6","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T10:03:39Z","timestamp":1722938619000},"page":"625-632","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Perception of pneumocystis jirovecii pneumonia (PJP) prophylaxis in glioma patients receiving concurrent temozolomide and radiation\u2013 a patient and physician survey"],"prefix":"10.1007","volume":"169","author":[{"given":"Ana-Alicia","family":"Beltran-Bless","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bader","family":"Alshamsan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seth","family":"Climans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garth","family":"Nicholas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terry L.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,6]]},"reference":[{"key":"4764_CR1","doi-asserted-by":"publisher","first-page":"e729","DOI":"10.1259\/bjr\/83796755","volume":"85","author":"K Rock","year":"2012","unstructured":"Rock K, McArdle O, Forde P et al (2012) A clinical review of treatment outcomes in glioblastoma multiforme\u2013the validation in a non-trial population of the results of a randomised phase III clinical trial: has a more radical approach improved survival? Br J Radiol 85:e729\u2013e733. https:\/\/doi.org\/10.1259\/bjr\/83796755","journal-title":"Br J Radiol"},{"key":"4764_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"key":"4764_CR3","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S1470-2045(21)00090-5","volume":"22","author":"MJ van den Bent","year":"2021","unstructured":"van den Bent MJ, Tesileanu CMS, Wick W et al (2021) Adjuvant and concurrent temozolomide for 1p\/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053\u2013\u200922054): second interim analysis of a randomised, open-label, phase 3 study. Lancet Oncol 22:813\u2013823. https:\/\/doi.org\/10.1016\/S1470-2045(21)00090-5","journal-title":"Lancet Oncol"},{"key":"4764_CR4","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1200\/JCO.2002.20.5.1375","volume":"20","author":"R Stupp","year":"2002","unstructured":"Stupp R, Dietrich P-Y, Ostermann Kraljevic S et al (2002) Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol 20:1375\u20131382. https:\/\/doi.org\/10.1200\/JCO.2002.20.5.1375","journal-title":"J Clin Oncol"},{"key":"4764_CR5","unstructured":"FDA (2016) Temozolomide (temodar)"},{"key":"4764_CR6","unstructured":"Accord, Healthcare (2017) Inc. ACH-TEMOZOLOMIDE"},{"key":"4764_CR7","unstructured":"NCCN (2021) Prevention and Treatment of Cancer-related infections. Version 1"},{"key":"4764_CR8","doi-asserted-by":"publisher","first-page":"e1003025","DOI":"10.1371\/journal.ppat.1003025","volume":"8","author":"F Gigliotti","year":"2012","unstructured":"Gigliotti F, Wright TW (2012) Pneumocystis: where does it live? PLoS Pathog 8:e1003025. https:\/\/doi.org\/10.1371\/journal.ppat.1003025","journal-title":"PLoS Pathog"},{"key":"4764_CR9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1086\/649868","volume":"50","author":"CA Ponce","year":"2010","unstructured":"Ponce CA, Gallo M, Bustamante R, Vargas SL (2010) Pneumocystis colonization is highly prevalent in the autopsied lungs of the general population. Clin Infect Dis 50:347\u2013353. https:\/\/doi.org\/10.1086\/649868","journal-title":"Clin Infect Dis"},{"key":"4764_CR10","doi-asserted-by":"publisher","first-page":"CD005590","DOI":"10.1002\/14651858.CD005590.pub3","volume":"2014","author":"A Stern","year":"2014","unstructured":"Stern A, Green H, Paul M et al (2014) Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Database Syst Rev 2014:CD005590. https:\/\/doi.org\/10.1002\/14651858.CD005590.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"4764_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.critrevonc.2012.08.002","volume":"85","author":"FY De Vos","year":"2013","unstructured":"De Vos FY, Gijtenbeek JM, Bleeker-Rovers CP, van Herpen CM (2013) Pneumocystis Jirovecii pneumonia prophylaxis during temozolomide treatment for high-grade gliomas. Crit Rev Oncol Hematol 85:373\u2013382. https:\/\/doi.org\/10.1016\/j.critrevonc.2012.08.002","journal-title":"Crit Rev Oncol Hematol"},{"key":"4764_CR12","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.ijrobp.2004.12.085","volume":"62","author":"MA Hughes","year":"2005","unstructured":"Hughes MA, Parisi M, Grossman S, Kleinberg L (2005) Primary brain tumors treated with steroids and radiotherapy: low CD4 counts and risk of infection. Int J Radiat Oncol Biol Phys 62:1423\u20131426. https:\/\/doi.org\/10.1016\/j.ijrobp.2004.12.085","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4764_CR13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1023\/a:1024217527650","volume":"63","author":"AK Mahindra","year":"2003","unstructured":"Mahindra AK, Grossman SA (2003) Pneumocystis carinii pneumonia in HIV negative patients with primary brain tumors. J Neurooncol 63:263\u2013270. https:\/\/doi.org\/10.1023\/a:1024217527650","journal-title":"J Neurooncol"},{"key":"4764_CR14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/BF00165480","volume":"27","author":"D Schiff","year":"1996","unstructured":"Schiff D (1996) Pneumocystis pneumonia in brain tumor patients: risk factors and clinical features. J Neurooncol 27:235\u2013240. https:\/\/doi.org\/10.1007\/BF00165480","journal-title":"J Neurooncol"},{"key":"4764_CR15","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1001\/archneur.1991.00530160074017","volume":"48","author":"JW Henson","year":"1991","unstructured":"Henson JW, Jalaj JK, Walker RW et al (1991) Pneumocystis carinii pneumonia in patients with primary brain tumors. Arch Neurol 48:406\u2013409. https:\/\/doi.org\/10.1001\/archneur.1991.00530160074017","journal-title":"Arch Neurol"},{"key":"4764_CR16","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/0002-9343(93)90187-t","volume":"94","author":"A Slivka","year":"1993","unstructured":"Slivka A, Wen PY, Shea WM, Loeffler JS (1993) Pneumocystis carinii pneumonia during steroid taper in patients with primary brain tumors. Am J Med 94:216\u2013219. https:\/\/doi.org\/10.1016\/0002-9343(93)90187-t","journal-title":"Am J Med"},{"key":"4764_CR17","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/s41416-018-0258-8","volume":"119","author":"NF Brown","year":"2018","unstructured":"Brown NF, Carter TJ, Ottaviani D, Mulholland P (2018) Harnessing the immune system in glioblastoma. Br J Cancer 119:1171\u20131181. https:\/\/doi.org\/10.1038\/s41416-018-0258-8","journal-title":"Br J Cancer"},{"key":"4764_CR18","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.4065\/82.9.1052","volume":"82","author":"H Green","year":"2007","unstructured":"Green H, Paul M, Vidal L, Leibovici L (2007) Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials. Mayo Clin Proc 82:1052\u20131059. https:\/\/doi.org\/10.4065\/82.9.1052","journal-title":"Mayo Clin Proc"},{"key":"4764_CR19","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1093\/neuonc\/noac072","volume":"24","author":"SA Climans","year":"2022","unstructured":"Climans SA, Grunfeld E, Mason WP, Chan KKW (2022) Effectiveness and safety of pneumocystis pneumonia prophylaxis for patients receiving temozolomide chemoradiotherapy. Neuro Oncol 24:1738\u20131748. https:\/\/doi.org\/10.1093\/neuonc\/noac072","journal-title":"Neuro Oncol"},{"key":"4764_CR20","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2217\/cns.14.24","volume":"3","author":"AJ Neuwelt","year":"2014","unstructured":"Neuwelt AJ, Nguyen TM, Fu R et al (2014) Incidence of Pneumocystis Jirovecii pneumonia after temozolomide for CNS malignancies without prophylaxis. CNS Oncol 3:267\u2013273. https:\/\/doi.org\/10.2217\/cns.14.24","journal-title":"CNS Oncol"},{"key":"4764_CR21","doi-asserted-by":"publisher","first-page":"116431","DOI":"10.1016\/j.jns.2019.116431","volume":"405","author":"N Rifino","year":"2019","unstructured":"Rifino N, Rigamonti A, Guida FM et al (2019) Lack of development of Pneumocystis Jirovecii Pneumonia in a cohort of 103 Italian glioblastoma patients not receiving prophylaxis during post-surgical chemoradiotherapy. J Neurol Sci 405:116431","journal-title":"J Neurol Sci"},{"key":"4764_CR22","unstructured":"Melendez Rivera JG, Ciofoaia GA (2023) Pneumocystis Jirovecii Prophylaxis. Treasure Island (FL)"},{"key":"4764_CR23","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1200\/jco.18.00374","volume":"36","author":"RA Taplitz","year":"2018","unstructured":"Taplitz RA, Kennedy EB, Bow EJ et al (2018) Antimicrobial prophylaxis for adult patients with Cancer-related immunosuppression: ASCO and IDSA Clinical Practice Guideline Update. J Clin Oncol 36:3043\u20133054. https:\/\/doi.org\/10.1200\/jco.18.00374","journal-title":"J Clin Oncol"},{"key":"4764_CR24","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.3390\/CURRONCOL28050337","volume":"28","author":"D Saunders","year":"2021","unstructured":"Saunders D, Liu M, Vandermeer L et al (2021) The rethinking clinical trials (REaCT) program. A canadian-led pragmatic trials program: strategies for integrating knowledge users into Trial Design. Curr Oncol 2021 28:3959\u20133977. https:\/\/doi.org\/10.3390\/CURRONCOL28050337","journal-title":"Curr Oncol 2021"},{"key":"4764_CR25","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.3390\/curroncol28050337","volume":"28","author":"D Saunders","year":"2021","unstructured":"Saunders D, Liu M, Vandermeer L et al (2021) The rethinking clinical trials (REaCT) program. A canadian-led pragmatic trials program: strategies for integrating knowledge users into Trial Design. Curr Oncol 28:3959\u20133977. https:\/\/doi.org\/10.3390\/curroncol28050337","journal-title":"Curr Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-024-04764-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-024-04764-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-024-04764-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T14:44:32Z","timestamp":1724424272000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-024-04764-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["4764"],"URL":"https:\/\/doi.org\/10.1007\/s11060-024-04764-6","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,6]]},"assertion":[{"value":"31 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ottawa Health Science Network Research Ethics Board (OHSN-REB).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Completion of the survey implied consent to participate.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}